Caraco launches generic dementia treatment

DETROIT Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco said.

The drug maker began shipping rivastigmine tartrate capsules. The capsules are used to treat mild to moderate dementia in patients with Alzheimer’s disease and Parkinson’s disease.

The drug is a generic version of Novartis’ Exelon, which has annual sales of around $130 million, according to Caraco.

Login or Register to post a comment.